Aster DM Healthcare Ltd


Aster DM Healthcare Ltd

Health CareHealth Care Providers
  • Price (INR)215.20
  • Today's Change3.30 / 1.56%
  • Shares traded104.31k
  • 1 Year change+14.47%
  • Beta1.2863
Data delayed at least 15 minutes, as of Feb 08 2023 10:12 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Aster DM Healthcare Limited is a healthcare service provider. The Company’s segments include Hospitals, Clinics and Retail Pharmacies. The Hospitals segment comprises of hospitals and in-house pharmacies at the hospitals. The Clinics segment comprises of clinics and in-house pharmacies at the clinics. The Retail Pharmacies segment comprises standalone retail pharmacies and optical outlets. The Company also comprises healthcare consultancy services. Its geographical segments consist of gulf corporation council (GCC) States, including United Arab Emirates, Qatar, Oman, Kingdom of Saudi Arabia, Jordan, Kuwait, Bahrain, India and Rest of the world. The Company's healthcare services are offered under Aster, Medcare and Access brands. The Company operates over five medical centers, approximately six pharmacies, one full-fledged diagnostic center and a multispecialty Aster Hospital.

  • Revenue in INR (TTM)108.56bn
  • Net income in INR4.89bn
  • Incorporated2008
  • Employees25.81k
  • Location
    Aster DM Healthcare Ltd33rd Floor, Tower D - Aspect Tower, ExecDUBAI 8703United Arab EmiratesARE
  • Phone+971 44546001
  • Fax+91 4 846699862
  • Websitehttp://www.asterdmhealthcare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
Dr. Ramesh Cardiac & Multispeciality Hospital Pvt LtdAnnounced29 Dec 202229 Dec 2022Announced-5.78%--
Sri Sainatha Multispeciality Hospitals Pvt LtdDeal completed20 Oct 202220 Oct 2022Deal completed-12.79%3.01m
Data delayed at least 15 minutes, as of Feb 08 2023 10:12 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Thyrocare Technologies Ltd5.11bn799.00m25.88bn2.12k30.625.2522.295.0715.9715.97102.3893.070.8856.345.122,414,752.0013.8522.3215.6924.9170.1470.9315.6424.433.2070.910.035471.4419.0514.1155.6732.680.79148.45
Healthcare Global Enterprises Ltd15.48bn-263.57m39.31bn5.68k--4.4631.902.54-2.16-2.16112.8763.350.713921.006.432,725,177.00-1.83-3.53-2.39-4.9153.7454.58-2.57-6.060.9631.070.5028--38.2114.78127.7718.49-18.05--
Vijaya Diagnostic Centre Ltd4.52bn897.74m44.39bn1.82k49.698.8729.849.828.758.7544.0749.020.624813.0459.192,486,730.0012.49--13.83--85.87--19.99--3.656.940.314--22.75--29.83------
Metropolis Healthcare Ltd11.79bn1.55bn64.00bn4.53k41.526.6927.465.4330.1030.10229.33186.840.88386.009.312,601,854.0011.6519.7014.4225.2376.9474.5913.1816.950.99318.610.241425.1723.0817.6616.9816.0713.06--
Rainbow Children's Medicare Ltd10.11bn1.56bn77.47bn2.54k48.998.1931.567.6615.5815.58100.6593.230.71848.5317.853,980,350.0011.20--12.43--84.63--15.59--2.675.150.3699--49.80--245.51------
Aster DM Healthcare Ltd108.56bn4.89bn105.38bn25.81k21.562.548.480.97079.839.83217.8683.390.84763.725.144,206,685.004.283.476.445.2363.0861.495.054.130.7662.800.5289--19.1111.57256.0238.89-10.08--
Krishna Institute Of Medical Sciencs Ltd18.25bn3.29bn116.44bn7.82k36.447.4325.836.3839.9339.93220.85195.710.841910.0111.142,335,882.0016.279.4120.6613.2078.5154.0319.3310.011.5339.830.20460.0024.1323.8265.3359.1811.16--
Narayana Hrudayalaya Ltd40.76bn4.46bn148.47bn11.47k33.328.3023.373.6421.9521.95200.7088.081.2224.6210.943,555,383.0013.334.2217.975.3958.8343.5510.943.831.058.820.3227--43.3314.532,490.4632.71----
Dr. Lal PathLabs Ltd20.11bn2.44bn158.72bn4.11k65.30--40.027.8929.3229.32242.23--------4,893,937.00--18.99--22.9477.3775.5512.2417.17--8.55--32.5232.0118.0018.2517.4155.9731.95
Fortis Healthcare Ltd59.40bn5.11bn209.88bn2.86k40.993.0223.693.536.786.7878.7892.030.491512.7010.9420,761,280.004.81-0.61785.87-0.857275.0573.569.79-1.420.80447.340.1365--41.874.57605.755.65-4.94--
Max Healthcare Institute Ltd42.83bn9.76bn427.03bn4.44k43.75--35.399.9710.0510.0544.10--------9,656,064.00--------79.55--22.79----7.11----56.97--539.88------
Abbott India Ltd51.63bn8.82bn446.05bn3.60k50.5916.4346.928.64414.96414.962,429.831,277.451.324.1016.4714,354,270.0022.5518.4631.8925.4645.8743.5417.0814.451.8762.430.045366.6314.1410.8515.6423.6215.4329.38
Data as of Feb 08 2023. Currency figures normalised to Aster DM Healthcare Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

12.52%Per cent of shares held by top holders
HolderShares% Held
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Dec 202220.13m4.03%
ICICI Prudential Asset Management Co. Ltd.as of 31 Dec 202212.16m2.43%
SBI Funds Management Pvt Ltd.as of 31 Dec 20228.99m1.80%
The Vanguard Group, Inc.as of 05 Jan 20238.23m1.65%
Steinberg Asset Management LLCas of 31 Mar 20226.90m1.38%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Dec 20221.56m0.31%
Dimensional Fund Advisors LPas of 05 Jan 20231.43m0.29%
East Capital Financial Services ABas of 30 Dec 20221.12m0.22%
Norges Bank Investment Managementas of 31 Dec 20211.02m0.20%
Fidelity Management & Research Co. LLCas of 31 Dec 2022989.53k0.20%
More ▼
Data from 31 Dec 2021 - 02 Feb 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.